Effects of environmental manipulations in genetically targeted animal models of affective disorders

Neurobiology of Disease

Volumn 57, Issue , 2013, Pages 12-27

  Renoir, Thibault ^a   Pang, Terence Y ^a   Hannan, Anthony J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Anxiety; Depression; Environmental enrichment; Exercise; Neuroplasticity; Stress; Transgenic animal models

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; AMITRIPTYLINE; BRAIN DERIVED NEUROTROPHIC FACTOR; CANNABINOID 1 RECEPTOR; CATECHOL METHYLTRANSFERASE; CATECHOLAMINE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; CYTOKINE; DOPAMINE TRANSPORTER; GAMMA INTERFERON; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; NERVE GROWTH FACTOR; NEUROTROPHIN 3; NEUROTROPHIN 4; NORADRENALIN TRANSPORTER; PHOSPHOLIPASE C BETA1; SEROTONIN; SEROTONIN TRANSPORTER; TUMOR NECROSIS FACTOR ALPHA; TYROSINE 3 MONOOXYGENASE; VESICULAR GLUTAMATE TRANSPORTER 1; VESICULAR GLUTAMATE TRANSPORTER 3;

ANIMAL BEHAVIOR; ANXIETY DISORDER; BRAIN FUNCTION; DEPRESSION; ELECTROENCEPHALOGRAM; ENDOPHENOTYPE; ENVIRONMENTAL ENRICHMENT; ENVIRONMENTAL FACTOR; ENVIRONMENTAL STRESS; ENZYME ACTIVITY; GABAERGIC SYSTEM; GENE TARGETING; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; INFLAMMATION; MOOD DISORDER; NEUROBIOLOGY; NEUROTRANSMISSION; NONHUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION;

ANIMALS; DISEASE MODELS, ANIMAL; GENE-ENVIRONMENT INTERACTION; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MOOD DISORDERS; NERVE GROWTH FACTORS; NEUROTRANSMITTER AGENTS; PITUITARY-ADRENAL SYSTEM;

EID: 84879787345     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2012.04.003     Document Type: Review

References (237)

1. Adamec R., et al. Vulnerability to mild predator stress in serotonin transporter knockout mice. Behav Brain Res. 2006, 170:126-140.
2. Agatsuma S., et al. Monoamine oxidase A knockout mice exhibit impaired nicotine preference but normal responses to novel stimuli. Hum. Mol. Genet. 2006, 15:2721-2731.
3. Aguilera M., et al. Early adversity and 5-HTT/BDNF genes: new evidence of gene-environment interactions on depressive symptoms in a general population. Psychol. Med. 2009, 39:1425-1432.
4. Amador-Arjona A., et al. Susceptibility to stress in transgenic mice overexpressing TrkC, a model of panic disorder. J. Psychiatr. Res. 2010, 44:157-167.
5. Amilhon B., et al. VGLUT3 (vesicular glutamate transporter type 3) contribution to the regulation of serotonergic transmission and anxiety. J. Neurosci. 2010, 30:2198-2210.
6. Appel K., et al. Moderation of adult depression by a polymorphism in the FKBP5 gene and childhood physical abuse in the general population. Neuropsychopharmacology 2011, 36:1982-1991.
7. Arnett M.G., et al. Behavioral insights from mouse models of forebrain- and amygdala-specific glucocorticoid receptor genetic disruption. Mol. Cell. Endocrinol. 2011, 336:2-5.
8. Bale T.L., Vale W.W. Increased depression-like behaviors in corticotropin-releasing factor receptor-2-deficient mice: sexually dichotomous responses. J. Neurosci. 2003, 23:5295-5301.
9. Bale T.L., et al. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat. Genet. 2000, 24:410-414.
10. Bale T.L., et al. Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior. J. Neurosci. 2002, 22:193-199.
11. Bao X., et al. Impaired chronotropic response to exercise in mice lacking catecholamines in adrenergic cells. Ann. N. Y. Acad. Sci. 2008, 1148:297-301.
12. Bartolomucci A., et al. Increased vulnerability to psychosocial stress in heterozygous serotonin transporter knockout mice. Dis. Model Mech. 2010, 3:459-470.
13. Basso A.M., et al. Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: relevance for neuropsychiatric disorders. Behav Brain Res. 2009, 198:83-90.
14. Bath K.G., et al. BDNF Val66Met impairs fluoxetine-induced enhancement of adult hippocampus plasticity. Neuropsychopharmacology 2012, 37:1297-1304.
15. Bhatnagar S., Vining C. Pituitary-adrenal activity in acute and chronically stressed male and female mice lacking the 5-HT-3A receptor. Stress 2004, 7:251-256.
16. Bhatnagar S., et al. Changes in anxiety-related behaviors and hypothalamic-pituitary-adrenal activity in mice lacking the 5-HT-3A receptor. Physiol. Behav. 2004, 81:545-555.
17. Binder E.B. The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology 2009, 34(Suppl. 1):S186-S195.
18. Bonilla-Jaime H., et al. Circadian activity of corticosterone in an animal model of depression: response to muscarinic cholinergic stimulation. Physiol. Behav. 2010, 100:311-315.
19. Bortolato M., et al. Behavioral disinhibition and reduced anxiety-like behaviors in monoamine oxidase B-deficient mice. Neuropsychopharmacology 2009, 34:2746-2757.
20. Boyce-Rustay J.M., Holmes A. Genetic inactivation of the NMDA receptor NR2A subunit has anxiolytic- and antidepressant-like effects in mice. Neuropsychopharmacology 2006, 31:2405-2414.
21. Boyle M.P., et al. Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:473-478.
22. Boyle M.P., et al. Forebrain glucocorticoid receptors modulate anxiety-associated locomotor activation and adrenal responsiveness. J. Neurosci. 2006, 26:1971-1978.
23. Bozdagi O., et al. The neurotrophin-inducible gene Vgf regulates hippocampal function and behavior through a brain-derived neurotrophic factor-dependent mechanism. J. Neurosci. 2008, 28:9857-9869.
24. Carroll J.C., et al. Effects of mild early life stress on abnormal emotion-related behaviors in 5-HTT knockout mice. Behav. Genet. 2007, 37:214-222.
25. Carta M.G., et al. Improving physical quality of life with group physical activity in the adjunctive treatment of major depressive disorder. Clin. Pract. Epidemiol. Ment. Health 2008, 4:1.
26. Caspi A., et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003, 301:386-389.
27. Catts V.S., et al. The p75 neurotrophin receptor regulates hippocampal neurogenesis and related behaviours. Eur. J. Neurosci. 2008, 28:883-892.
28. Chen A., et al. Urocortin 2-deficient mice exhibit gender-specific alterations in circadian hypothalamus-pituitary-adrenal axis and depressive-like behavior. J. Neurosci. 2006, 26:5500-5510.
29. Chen Z.Y., et al. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 2006, 314:140-143.
30. Chou-Green J.M., et al. Repeated stress in young and old 5-HT (2C) receptor knockout mice. Physiol. Behav. 2003, 79:217-226.
31. Chourbaji S., et al. Mice with reduced brain-derived neurotrophic factor expression show decreased choline acetyltransferase activity, but regular brain monoamine levels and unaltered emotional behavior. Brain Res. Mol. Brain Res. 2004, 121:28-36.
32. Chourbaji S., et al. IL-6 knockout mice exhibit resistance to stress-induced development of depression-like behaviors. Neurobiol. Dis. 2006, 23:587-594.
33. Chourbaji S., et al. Dopamine receptor 3 (D3) knockout mice show regular emotional behaviour. Pharmacol. Res. 2008, 58:302-307.
34. Christian K.M., et al. Chronic stress-induced hippocampal dendritic retraction requires CA3 NMDA receptors. Neuroscience 2011, 174:26-36.
35. Compan V., et al. Attenuated response to stress and novelty and hypersensitivity to seizures in 5-HT4 receptor knock-out mice. J. Neurosci. 2004, 24:412-419.
36. Conn P.J., Niswender C.M. mGluR7's lucky number. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:251-252.
37. Coste S.C., et al. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat. Genet. 2000, 24:403-409.
38. Coste S.C., et al. Corticotropin-releasing factor receptor type 2-deficient mice display impaired coping behaviors during stress. Genes Brain Behav. 2006, 5:131-138.
39. Cotel M.C., et al. Environmental enrichment fails to rescue working memory deficits, neuron loss, and neurogenesis in APP/PS1KI mice. Neurobiol. Aging 2012, 33:96-107.
40. Covington H.E., et al. Hippocampal-dependent antidepressant-like activity of histone deacetylase inhibition. Neurosci. Lett. 2011, 493:122-126.
41. Cracchiolo J.R., et al. Enhanced cognitive activity-over and above social or physical activity-is required to protect Alzheimer's mice against cognitive impairment, reduce Abeta deposition, and increase synaptic immunoreactivity. Neurobiol. Learn. Mem. 2007, 88:277-294.
42. Crestani F., et al. Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues. Nat. Neurosci. 1999, 2:833-839.
43. Cryan J.F., Holmes A. The ascent of mouse: advances in modelling human depression and anxiety. Nat. Rev. Drug Discov. 2005, 4:775-790.
44. Cryan J.F., et al. Use of dopamine-beta-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs. J. Pharmacol. Exp. Ther. 2001, 298:651-657.
45. Cryan J.F., et al. Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:8186-8191.
46. Dagyte G., et al. The cholinergic system and depression. Behav. Brain Res. 2011, 221:574-582.
47. Darlington D.N., et al. Paraventricular stimulation with glutamate elicits bradycardia and pituitary responses. Am. J. Physiol. 1989, 256:R112-R119.
48. David D.J., et al. Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 2009, 62:479-493.
49. Dubreucq S., et al. CB1 receptor deficiency decreases wheel-running activity: consequences on emotional behaviours and hippocampal neurogenesis. Exp. Neurol. 2010, 224:106-113.
50. Dulawa S.C., et al. Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli. J. Neurosci. 1999, 19:9550-9556.
51. Duman C.H. Models of depression. Vitam. Horm. 2010, 82:1-21.
52. Duman C.H., et al. Voluntary exercise produces antidepressant and anxiolytic behavioral effects in mice. Brain Res. 2008, 1199:148-158.
53. Dunn A.J., Swiergiel A.H. Behavioral responses to stress are intact in CRF-deficient mice. Brain Res. 1999, 845:14-20.
54. Dziedzicka-Wasylewska M., et al. Effect of antidepressant drugs in mice lacking the norepinephrine transporter. Neuropsychopharmacology 2006, 31:2424-2432.
55. Earnheart J.C., et al. GABAergic control of adult hippocampal neurogenesis in relation to behavior indicative of trait anxiety and depression states. J. Neurosci. 2007, 27:3845-3854.
56. Egashira N., et al. Altered depression-related behavior and neurochemical changes in serotonergic neurons in mutant R406W human tau transgenic mice. Brain Res. 2005, 1059:7-12.
57. Falzone T.L., et al. Absence of dopamine D4 receptors results in enhanced reactivity to unconditioned, but not conditioned, fear. Eur. J. Neurosci. 2002, 15:158-164.
58. Fergusson D.M., et al. Life stress, 5-HTTLPR and mental disorder: findings from a 30-year longitudinal study. Br. J. Psychiatry 2011, 198:129-135.
59. Fernandez S.P., Gaspar P. Investigating anxiety and depressive-like phenotypes in genetic mouse models of serotonin depletion. Neuropharmacology 2012, 62:144-154.
60. Filali M., et al. Cognitive and non-cognitive behaviors in an APPswe/PS1 bigenic model of Alzheimer's disease. Genes Brain Behav. 2009, 8:143-148.
61. Froger N., et al. Neurochemical and behavioral alterations in glucocorticoid receptor-impaired transgenic mice after chronic mild stress. J. Neurosci. 2004, 24:2787-2796.
62. Galeotti N., Ghelardini C. Antidepressant phenotype by inhibiting the phospholipase Cbeta(1)-protein kinase Cgamma pathway in the forced swim test. Neuropharmacology 2011, 60:937-943.
63. Gao S.F., Bao A.M. Corticotropin-releasing hormone, glutamate, and gamma-aminobutyric acid in depression. Neuroscientist 2011, 17:124-144.
64. Garcia-Garcia A.L., et al. Increased vulnerability to depressive-like behavior of mice with decreased expression of VGLUT1. Biol. Psychiatry 2009, 66:275-282.
65. Gogos J.A., et al. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:9991-9996.
66. Golden S.A., et al. A standardized protocol for repeated social defeat stress in mice. Nat. Protoc. 2011, 6:1183-1191.
67. Gortz N., et al. Effects of environmental enrichment on exploration, anxiety, and memory in female TgCRND8 Alzheimer mice. Behav. Brain Res. 2008, 191:43-48.
68. Goshen I., et al. Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol. Psychiatry 2008, 13:717-728.
69. Govindarajan A., et al. Transgenic brain-derived neurotrophic factor expression causes both anxiogenic and antidepressant effects. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:13208-13213.
70. Gray L., et al. Sensitivity to MK-801 in phospholipase C-beta1 knockout mice reveals a specific NMDA receptor deficit. Int. J. Neuropsychopharmacol. 2009, 12:917-928.
71. Greenwood B.N., et al. Freewheel running prevents learned helplessness/behavioral depression: role of dorsal raphe serotonergic neurons. J. Neurosci. 2003, 23:2889-2898.
72. Gresack J., et al. CRF2 null mutation increases sensitivity to isolation rearing effects on locomotor activity in mice. Neuropeptides 2010, 44:349-353.
73. Groenink L., et al. 5-HT1A receptor knockout mice and mice overexpressing corticotropin-releasing hormone in models of anxiety. Eur. J. Pharmacol. 2003, 463:185-197.
74. Groenink L., et al. 5-HT1A receptor and 5-HT1B receptor knockout mice in stress and anxiety paradigms. Behav. Pharmacol. 2003, 14:369-383.
75. Gross C., et al. Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 2002, 416:396-400.
76. Gysling K., et al. Corticotropin-releasing hormone and urocortin: redundant or distinctive functions?. Brain Res. Brain Res. Rev. 2004, 47:116-125.
77. Haenisch B., Bonisch H. Depression and antidepressants: insights from knockout of dopamine, serotonin or noradrenaline re-uptake transporters. Pharmacol. Ther. 2011, 129:352-368.
78. Haenisch B., et al. Knockout of the norepinephrine transporter and pharmacologically diverse antidepressants prevent behavioral and brain neurotrophin alterations in two chronic stress models of depression. J. Neurochem. 2009, 111:403-416.
79. Haller J., et al. Behavioral responses to social stress in noradrenaline transporter knockout mice: effects on social behavior and depression. Brain Res. Bull. 2002, 58:279-284.
80. Hartmann J., et al. The involvement of FK506-binding protein 51 (FKBP5) in the behavioral and neuroendocrine effects of chronic social defeat stress. Neuropharmacology 2012, 62:332-339.
81. Hedlund P.B., Sutcliffe J.G. The 5-HT7 receptor influences stereotypic behavior in a model of obsessive-compulsive disorder. Neurosci. Lett. 2007, 414:247-251.
82. Hedlund P.B., et al. 5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern. Biol. Psychiatry 2005, 58:831-837.
83. Heiming R.S., et al. Living in a dangerous world: the shaping of behavioral profile by early environment and 5-HTT genotype. Front. Behav. Neurosci. 2009, 3:26.
84. Hendricks T.J., et al. Pet-1 ETS gene plays a critical role in 5-HT neuron development and is required for normal anxiety-like and aggressive behavior. Neuron 2003, 37:233-247.
85. Herman J.P., et al. Role of GABA and glutamate circuitry in hypothalamo-pituitary-adrenocortical stress integration. Ann. N. Y. Acad. Sci. 2004, 1018:35-45.
86. Hiroi N., et al. Expression of corticotropin releasing hormone receptors type I and type II mRNA in suicide victims and controls. Mol. Psychiatry 2001, 6:540-546.
87. Holmes A., et al. Evaluation of antidepressant-related behavioral responses in mice lacking the serotonin transporter. Neuropsychopharmacology 2002, 27:914-923.
88. Holmes A., et al. Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background. Genes Brain Behav. 2003, 2:365-380.
89. Holmes A., et al. Mice lacking the serotonin transporter exhibit 5-HT (1A) receptor-mediated abnormalities in tests for anxiety-like behavior. Neuropsychopharmacology 2003, 28:2077-2088.
90. Hosang G.M., et al. Stressful life events and the brain-derived neurotrophic factor gene in bipolar disorder. J. Affect. Disord. 2010, 125:345-349.
91. Hranilovic D., et al. Emotional response in dopamine D2L receptor-deficient mice. Behav. Brain Res. 2008, 195:246-250.
92. Hunsberger J.G., et al. Antidepressant actions of the exercise-regulated gene VGF. Nat. Med. 2007, 13:1476-1482.
93. Jacobsen K.X., et al. Region-specific regulation of 5-HT1A receptor expression by Pet-1-dependent mechanisms in vivo. J. Neurochem. 2011, 116:1066-1076.
94. Jankowsky J.L., et al. Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's disease. J. Neurosci. 2005, 25:5217-5224.
95. Jansen F., et al. Modulation of behavioural profile and stress response by 5-HTT genotype and social experience in adulthood. Behav. Brain Res. 2010, 207:21-29.
96. Jansen F., et al. Away game or home match: the influence of venue and serotonin transporter genotype on the display of offensive aggression. Behav. Brain Res. 2011, 219:291-301.
97. Jeanneteau F.D., et al. BDNF and glucocorticoids regulate corticotrophin-releasing hormone (CRH) homeostasis in the hypothalamus. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:1305-1310.
98. Joeyen-Waldorf J., et al. The roles of sex and serotonin transporter levels in age- and stress-related emotionality in mice. Brain Res. 2009, 1286:84-93.
99. Jones M.D., Lucki I. Sex differences in the regulation of serotonergic transmission and behavior in 5-HT receptor knockout mice. Neuropsychopharmacology 2005, 30:1039-1047.
100. Kaestner F., et al. Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity. J. Affect. Disord. 2005, 87:305-311.
101. Kasahara M., et al. Altered behavioural adaptation in mice with neural corticotrophin-releasing factor overexpression. Genes Brain Behav. 2007, 6:598-607.
102. Kaster M.P., et al. Depressive-like behavior induced by tumor necrosis factor-alpha in mice. Neuropharmacology 2012, 62:419-426.
103. Kaufman J., et al. Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol. Psychiatry 2006, 59:673-680.
104. Kelley S.P., et al. Targeted gene deletion of the 5-HT3A receptor subunit produces an anxiolytic phenotype in mice. Eur. J. Pharmacol. 2003, 461:19-25.
105. Kerman I.A., et al. Inborn differences in environmental reactivity predict divergent diurnal behavioral, endocrine, and gene expression rhythms. Psychoneuroendocrinology 2012, 37(2):256-269. (Feb).
106. Kishimoto T., et al. Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nat. Genet. 2000, 24:415-419.
107. Koehl M., et al. Exercise-induced promotion of hippocampal cell proliferation requires beta-endorphin. FASEB J. 2008, 22:2253-2262.
108. Kolber B.J., et al. Hypothalamic-pituitary-adrenal axis dysregulation and behavioral analysis of mouse mutants with altered glucocorticoid or mineralocorticoid receptor function. Stress 2008, 11:321-338.
109. Kondo M., et al. Environmental enrichment ameliorates a motor coordination deficit in a mouse model of Rett syndrome-Mecp2 gene dosage effects and BDNF expression. Eur. J. Neurosci. 2008, 27:3342-3350.
110. Koo J.W., Duman R.S. IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:751-756.
111. Kuperman Y., et al. Perifornical Urocortin-3 mediates the link between stress-induced anxiety and energy homeostasis. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:8393-8398.
112. Kusserow H., et al. Reduced anxiety-related behaviour in transgenic mice overexpressing serotonin 1A receptors. Brain Res. Mol. Brain Res. 2004, 129:104-116.
113. Lanfumey L., et al. 5-HT-HPA interactions in two models of transgenic mice relevant to major depression. Neurochem. Res. 2000, 25:1199-1206.
114. Lanquillon S., et al. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 2000, 22:370-379.
115. Laske C., et al. Exercise-induced normalization of decreased BDNF serum concentration in elderly women with remitted major depression. Int. J. Neuropsychopharmacol. 2010, 13:595-602.
116. Laviola G., et al. Effects of enriched environment on animal models of neurodegenerative diseases and psychiatric disorders. Neurobiol. Dis. 2008, 31:159-168.
117. Lazarov O., et al. Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 2005, 120:701-713.
118. Lee D.L., et al. Hypertensive response to acute stress is attenuated in interleukin-6 knockout mice. Hypertension 2004, 44:259-263.
119. Lee M., et al. MAO-B knockout mice exhibit deficient habituation of locomotor activity but normal nicotine intake. Genes. Brain Behav. 2004, 3:216-227.
120. Leggio G.M., et al. Dopamine D3 receptor knock-out mice exhibit increased behavioral sensitivity to the anxiolytic drug diazepam. Eur. Neuropsychopharmacol. 2011, 21:325-332.
121. Lehmann M.L., Herkenham M. Environmental enrichment confers stress resiliency to social defeat through an infralimbic cortex-dependent neuroanatomical pathway. J. Neurosci. 2011, 31:6159-6173.
122. Lesch K.P., et al. Anxiety-related traits in mice with modified genes of the serotonergic pathway. Eur. J. Pharmacol. 2003, 480:185-204.
123. Lewejohann L., et al. Social status and day-to-day behaviour of male serotonin transporter knockout mice. Behav. Brain Res. 2010, 211:220-228.
124. Lewis K., et al. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:7570-7575.
125. Li Y., et al. TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment. Neuron 2008, 59:399-412.
126. Li W.J., et al. Anxiolytic effect of music exposure on BDNFMet/Met transgenic mice. Brain Res. 2010, 1347:71-79.
127. Linthorst A.C., et al. Glucocorticoid receptor impairment alters CNS responses to a psychological stressor: an in vivo microdialysis study in transgenic mice. Eur. J. Neurosci. 2000, 12:283-291.
128. Lira A., et al. Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biol. Psychiatry 2003, 54:960-971.
129. Litteljohn D., et al. Interferon-gamma deficiency modifies the effects of a chronic stressor in mice: implications for psychological pathology. Brain Behav. Immun. 2010, 24:462-473.
130. Liu G.X., et al. Reduced anxiety and depression-like behaviors in mice lacking GABA transporter subtype 1. Neuropsychopharmacology 2007, 32:1531-1539.
131. Lonetti G., et al. Early environmental enrichment moderates the behavioral and synaptic phenotype of MeCP2 null mice. Biol. Psychiatry 2010, 67:657-665.
132. Lu A., et al. Conditional mouse mutants highlight mechanisms of corticotropin-releasing hormone effects on stress-coping behavior. Mol. Psychiatry 2008, 13:1028-1042.
133. Luscher B., et al. The GABAergic deficit hypothesis of major depressive disorder. Mol. Psychiatry 2011, 16:383-406.
134. Lyons W.E., et al. Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:15239-15244.
135. MacQueen G.M., et al. Performance of heterozygous brain-derived neurotrophic factor knockout mice on behavioral analogues of anxiety, nociception, and depression. Behav. Neurosci. 2001, 115:1145-1153.
136. Maes M., et al. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab. Brain Dis. 2009, 24:27-53.
137. Makara G.B., Stark E. Effect of intraventricular glutamate on ACTH release. Neuroendocrinology 1975, 18:213-216.
138. Mandolesi G., et al. NGF-dependent and tissue-specific transcription of vgf is regulated by a CREB-p300 and bHLH factor interaction. FEBS Lett. 2002, 510:50-56.
139. Manning E.E., et al. Increased adult hippocampal neurogenesis and abnormal migration of adult-born granule neurons is associated with hippocampal-specific cognitive deficits in phospholipase C-beta1 knockout mice. Hippocampus 2012, 22(2):309-319. (Feb).
140. Marsden W.N. Stressor-induced NMDAR dysfunction as a unifying hypothesis for the aetiology, pathogenesis and comorbidity of clinical depression. Med. Hypotheses 2011, 77:508-528.
141. Martin M., et al. Involvement of CB1 cannabinoid receptors in emotional behaviour. Psychopharmacology (Berl) 2002, 159:379-387.
142. Martinowich K., et al. Roles of p75 (NTR), long-term depression, and cholinergic transmission in anxiety and acute stress coping. Biol. Psychiatry 2012, 71(1):75-83. (Jan 1).
143. Martisova E., et al. Long lasting effects of early-life stress on glutamatergic/GABAergic circuitry in the rat hippocampus. Neuropharmacology 2012, 62:1944-1953.
144. McOmish C.E., et al. Phospholipase C-beta1 knockout mice exhibit endophenotypes modeling schizophrenia which are rescued by environmental enrichment and clozapine administration. Mol. Psychiatry 2008, 13:661-672.
145. Mitsukawa K., et al. Metabotropic glutamate receptor subtype 7 ablation causes dysregulation of the HPA axis and increases hippocampal BDNF protein levels: implications for stress-related psychiatric disorders. Neuropsychopharmacology 2006, 31:1112-1122.
146. Miyamoto Y., et al. Hyperfunction of dopaminergic and serotonergic neuronal systems in mice lacking the NMDA receptor epsilon1 subunit. J. Neurosci. 2001, 21:750-757.
147. Miyamoto Y., et al. Lower sensitivity to stress and altered monoaminergic neuronal function in mice lacking the NMDA receptor epsilon 4 subunit. J. Neurosci. 2002, 22:2335-2342.
148. Moghaddam B. Stress preferentially increases extraneuronal levels of excitatory amino acids in the prefrontal cortex: comparison to hippocampus and basal ganglia. J. Neurochem. 1993, 60:1650-1657.
149. Mombereau C., et al. Genetic and pharmacological evidence of a role for GABA(B) receptors in the modulation of anxiety- and antidepressant-like behavior. Neuropsychopharmacology 2004, 29:1050-1062.
150. Mombereau C., et al. Altered anxiety and depression-related behaviour in mice lacking GABAB(2) receptor subunits. Neuroreport 2005, 16:307-310.
151. Monteggia L.M., et al. Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biol. Psychiatry 2007, 61:187-197.
152. Mueller A., et al. Interaction of serotonin transporter gene-linked polymorphic region and stressful life events predicts cortisol stress response. Neuropsychopharmacology 2011, 36:1332-1339.
153. Muller M.B., et al. Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress. Nat. Neurosci. 2003, 6:1100-1107.
154. Muller J.M., et al. Serotonin transporter deficient mice are vulnerable to escape deficits following inescapable shocks. Genes. Brain Behav. 2011, 10:166-175.
155. Munafo M.R., et al. Gene×environment interactions at the serotonin transporter locus. Biol. Psychiatry 2009, 65:211-219.
156. Nederhof E., et al. Interaction between childhood adversity, brain-derived neurotrophic factor val/met and serotonin transporter promoter polymorphism on depression: the TRAILS study. Biol. Psychiatry 2010, 68:209-212.
157. Nelson R.L., et al. Prophylactic treatment with paroxetine ameliorates behavioral deficits and retards the development of amyloid and tau pathologies in 3xTgAD mice. Exp. Neurol. 2007, 205:166-176.
158. Nestler E.J., Hyman S.E. Animal models of neuropsychiatric disorders. Nat. Neurosci. 2010, 13:1161-1169.
159. Neufeld-Cohen A., et al. Urocortin-1 and -2 double-deficient mice show robust anxiolytic phenotype and modified serotonergic activity in anxiety circuits. Mol. Psychiatry. 2010, 15(426-41):339.
160. Ninan I., et al. The BDNF Val66Met polymorphism impairs NMDA receptor-dependent synaptic plasticity in the hippocampus. J. Neurosci. 2010, 30:8866-8870.
161. Nithianantharajah J., Hannan A.J. Enriched environments, experience-dependent plasticity and disorders of the nervous system. Nat. Rev. Neurosci. 2006, 7:697-709.
162. Nonogaki K., et al. Hyperactivity and reduced energy cost of physical activity in serotonin 5-HT (2C) receptor mutant mice. Diabetes 2003, 52:315-320.
163. Paizanis E., et al. Behavioural and neuroplastic effects of the new-generation antidepressant agomelatine compared to fluoxetine in glucocorticoid receptor-impaired mice. Int. J. Neuropsychopharmacol. 2010, 13:759-774.
164. Pang T.Y., et al. Differential effects of voluntary physical exercise on behavioral and brain-derived neurotrophic factor expression deficits in Huntington's disease transgenic mice. Neuroscience 2006, 141:569-584.
165. Pang T.Y., et al. Altered serotonin receptor expression is associated with depression-related behavior in the R6/1 transgenic mouse model of Huntington's disease. Hum. Mol. Genet. 2009, 18:753-766.
166. Pascual A., et al. Absolute requirement of GDNF for adult catecholaminergic neuron survival. Nat. Neurosci. 2008, 11:755-761.
167. Perona M.T., et al. Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions. Behav. Pharmacol. 2008, 19:566-574.
168. Pilu A., et al. Efficacy of physical activity in the adjunctive treatment of major depressive disorders: preliminary results. Clin. Pract. Epidemiol. Ment. Health 2007, 3:8.
169. Pogorelov V.M., et al. Novelty seeking and stereotypic activation of behavior in mice with disruption of the Dat1 gene. Neuropsychopharmacology 2005, 30:1818-1831.
170. Polter A.M., Li X. 5-HT1A receptor-regulated signal transduction pathways in brain. Cell. Signal. 2010, 22:1406-1412.
171. Popova N.K., Tibeikina M.A. Immobility and hyperthermia in the tail suspension test: association with the Porsolt test and the reflex startle reaction in 11 inbred mouse strains and the effects of genetic knockout of MAO A. Neurosci. Behav. Physiol. 2010, 40:489-494.
172. Popova N.K., et al. Behavioral characteristics of mice with genetic knockout of monoamine oxidase type A. Neurosci. Behav. Physiol. 2001, 31:597-602.
173. Popova N.K., et al. MAO A knockout attenuates adrenocortical response to various kinds of stress. Psychoneuroendocrinology 2006, 31:179-186.
174. Pugh P.L., et al. Non-cognitive behaviours in an APP/PS1 transgenic model of Alzheimer's disease. Behav. Brain Res. 2007, 178:18-28.
175. Raison C.L., Miller A.H. Is depression an inflammatory disorder?. Curr. Psychiatry. Rep. 2011, 13:467-475.
176. Renoir T., et al. Differential long-term effects of MDMA on the serotoninergic system and hippocampal cell proliferation in 5-HTT knock-out vs. wild-type mice. Int. J. Neuropsychopharmacol. 2008, 11:1149-1162.
177. Renoir T., et al. Sexually dimorphic serotonergic dysfunction in a mouse model of Huntington's disease and depression. PLoS One 2011, 6:e22133.
178. Renoir T., et al. Treatment of depressive-like behaviour in Huntington's disease mice by chronic sertraline and exercise. Br. J. Pharmacol. 2012, 165(5):1375-1389. (Mar).
179. Ressler K.J., et al. Polymorphisms in CRHR1 and the serotonin transporter loci: gene×gene×environment interactions on depressive symptoms. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010, 153B:812-824.
180. Reyes T.M., et al. Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:2843-2848.
181. Richardson-Jones J.W., et al. Serotonin-1A autoreceptors are necessary and sufficient for the normal formation of circuits underlying innate anxiety. J. Neurosci. 2011, 31:6008-6018.
182. Richter H., et al. Wheel-running in a transgenic mouse model of Alzheimer's disease: protection or symptom?. Behav. Brain Res. 2008, 190:74-84.
183. Ridder S., et al. Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions. J. Neurosci. 2005, 25:6243-6250.
184. Rios M., et al. Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol. Endocrinol. 2001, 15:1748-1757.
185. Risch N., et al. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAMA 2009, 301:2462-2471.
186. Rossi C., et al. Brain-derived neurotrophic factor (BDNF) is required for the enhancement of hippocampal neurogenesis following environmental enrichment. Eur. J. Neurosci. 2006, 24:1850-1856.
187. Rotzinger S., et al. Behavioral effects of neuropeptides in rodent models of depression and anxiety. Peptides 2010, 31:736-756.
188. Saarelainen T., et al. Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J. Neurosci. 2003, 23:349-357.
189. Sale A., et al. Enrich the environment to empower the brain. Trends Neurosci. 2009, 32:233-239.
190. Sallinen J., et al. Genetic alteration of the alpha2-adrenoceptor subtype C in mice affects the development of behavioral despair and stress-induced increases in plasma corticosterone levels. Mol. Psychiatry 1999, 4:443-452.
191. Schloesser R.J., et al. Environmental enrichment requires adult neurogenesis to facilitate the recovery from psychosocial stress. Mol. Psychiatry 2010, 15:1152-1163.
192. Schulte-Herbruggen O., et al. Differential regulation of neurotrophins and serotonergic function in mice with genetically reduced glucocorticoid receptor expression. Exp. Neurol. 2007, 204:307-316.
193. Shen Q., et al. gamma-Aminobutyric acid-type A receptor deficits cause hypothalamic-pituitary-adrenal axis hyperactivity and antidepressant drug sensitivity reminiscent of melancholic forms of depression. Biol. Psychiatry 2010, 68:512-520.
194. Simen B.B., et al. TNFalpha signaling in depression and anxiety: behavioral consequences of individual receptor targeting. Biol. Psychiatry 2006, 59:775-785.
195. Sinclair D., et al. Abnormal glucocorticoid receptor mRNA and protein isoform expression in the prefrontal cortex in psychiatric illness. Neuropsychopharmacology 2011, 36:2698-2709.
196. Skeldal S., et al. Proteolytic processing of the p75 neurotrophin receptor: a prerequisite for signalling?: Neuronal life, growth and death signalling are crucially regulated by intra-membrane proteolysis and trafficking of p75 (NTR). Bioessays 2011, 33:614-625.
197. Smith G.W., et al. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 1998, 20:1093-1102.
198. Sotelo C., et al. Direct immunohistochemical evidence of the existence of 5-HT1A autoreceptors on serotoninergic neurons in the midbrain raphe nuclei. Eur. J. Neurosci. 1990, 2:1144-1154.
199. Spires T.L., et al. Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism. J. Neurosci. 2004, 24:2270-2276.
200. Steiner H., et al. D3 dopamine receptor-deficient mouse: evidence for reduced anxiety. Physiol. Behav. 1997, 63:137-141.
201. Steiner M.A., et al. Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice. Pharmacogenomics J. 2008, 8:196-208.
202. Surget A., et al. Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal. Biol. Psychiatry 2008, 64:293-301.
203. Tanaka M., Telegdy G. Antidepressant-like effects of the CRF family peptides, urocortin 1, urocortin 2 and urocortin 3 in a modified forced swimming test in mice. Brain Res. Bull. 2008, 75:509-512.
204. Thakker-Varia S., et al. The neuropeptide VGF produces antidepressant-like behavioral effects and enhances proliferation in the hippocampus. J. Neurosci. 2007, 27:12156-12167.
205. Thiemann G., et al. Modulation of anxiety by acute blockade and genetic deletion of the CB(1) cannabinoid receptor in mice together with biogenic amine changes in the forebrain. Behav. Brain Res. 2009, 200:60-67.
206. Timpl P., et al. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat. Genet. 1998, 19:162-166.
207. Todorovic C., et al. Suppression of the MEK/ERK signaling pathway reverses depression-like behaviors of CRF2-deficient mice. Neuropsychopharmacology 2009, 34:1416-1426.
208. Tordera R.M., et al. Enhanced anxiety, depressive-like behaviour and impaired recognition memory in mice with reduced expression of the vesicular glutamate transporter 1 (VGLUT1). Eur. J. Neurosci. 2007, 25:281-290.
209. Toth M. Use of mice with targeted genetic inactivation in the serotonergic system for the study of anxiety. Serotonin Receptors in Neurobiology, Boca Raton (FL) 2007, A. Chattopadhyay (Ed.).
210. Touma C., et al. Age- and sex-dependent development of adrenocortical hyperactivity in a transgenic mouse model of Alzheimer's disease. Neurobiol. Aging 2004, 25:893-904.
211. Touma C., et al. Rhythmicity in mice selected for extremes in stress reactivity: behavioural, endocrine and sleep changes resembling endophenotypes of major depression. PLoS One 2009, 4:e4325.
212. Touma C., et al. FK506 binding protein 5 shapes stress responsiveness: modulation of neuroendocrine reactivity and coping behavior. Biol. Psychiatry 2011, 70:928-936.
213. Trejo J.L., et al. The effects of exercise on spatial learning and anxiety-like behavior are mediated by an IGF-I-dependent mechanism related to hippocampal neurogenesis. Mol. Cell. Neurosci. 2008, 37:402-411.
214. Tronche F., et al. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat. Genet. 1999, 23:99-103.
215. Uchida S., et al. Epigenetic status of Gdnf in the ventral striatum determines susceptibility and adaptation to daily stressful events. Neuron 2011, 69:359-372.
216. van Dellen A., et al. Delaying the onset of Huntington's in mice. Nature 2000, 404:721-722.
217. van Gaalen M.M., et al. Effects of transgenic overproduction of CRH on anxiety-like behaviour. Eur. J. Neurosci. 2002, 15:2007-2015.
218. van Praag H., et al. Neural consequences of environmental enrichment. Nat. Rev. Neurosci. 2000, 1:191-198.
219. van Zuiden M., et al. Pre-existing high glucocorticoid receptor number predicting development of posttraumatic stress symptoms after military deployment. Am. J. Psychiatry 2011, 168:89-96.
220. Vaughan J., et al. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 1995, 378:287-292.
221. Vetter D.E., et al. Urocortin-deficient mice show hearing impairment and increased anxiety-like behavior. Nat. Genet. 2002, 31:363-369.
222. Vicentini E., et al. Transient forebrain over-expression of CRF induces plasma corticosterone and mild behavioural changes in adult conditional CRF transgenic mice. Pharmacol. Biochem. Behav. 2009, 93:17-24.
223. Vloeberghs E., et al. Aggressive male APP23 mice modeling behavioral alterations in dementia. Behav. Neurosci. 2006, 120:1380-1383.
224. Vloeberghs E., et al. Mood and male sexual behaviour in the APP23 model of Alzheimer's disease. Behav. Brain Res. 2007, 180:146-151.
225. Wagner K.V., et al. Pituitary glucocorticoid receptor deletion reduces vulnerability to chronic stress. Psychoneuroendocrinology 2011, 36:579-587.
226. Wakabayashi C., et al. Age-dependent regulation of depression-like behaviors through modulation of adrenergic receptor alphaA subtype expression revealed by the analysis of interleukin-1 receptor antagonist knockout mice. Neuroscience 2011, 192:475-484.
227. Wang X.D., et al. Forebrain CRHR1 deficiency attenuates chronic stress-induced cognitive deficits and dendritic remodeling. Neurobiol. Dis. 2011, 42:300-310.
228. Weisstaub N.V., et al. Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. Science 2006, 313:536-540.
229. Wellman C.L., et al. Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin transporter knock-out mice. J. Neurosci. 2007, 27:684-691.
230. Weninger S.C., et al. Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:8283-8288.
231. Xu F., et al. Mice lacking the norepinephrine transporter are supersensitive to psychostimulants. Nat. Neurosci. 2000, 3:465-471.
232. Yuen E.Y., et al. Repeated stress causes cognitive impairment by suppressing glutamate receptor expression and function in prefrontal cortex. Neuron 2012, 73:962-977.
233. Zaheer A., et al. GMF-knockout mice are unable to induce brain-derived neurotrophic factor after exercise. Neurochem. Res. 2006, 31:579-584.
234. Zajac M.S., et al. Wheel running and environmental enrichment differentially modify exon-specific BDNF expression in the hippocampus of wild-type and pre-motor symptomatic male and female Huntington's disease mice. Hippocampus 2010, 20:621-636.
235. Zanettini C., et al. Postnatal handling reverses social anxiety in serotonin receptor 1A knockout mice. Genes. Brain Behav. 2010, 9:26-32.
236. Zimmermann P., et al. Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: results from a 10-year prospective community study. Am. J. Psychiatry 2011, 168:1107-1116.
237. Zorner B., et al. Forebrain-specific trkB-receptor knockout mice: behaviorally more hyperactive than "depressive". Biol. Psychiatry 2003, 54:972-982.